Skip to content

Clinical trials

Carcinoma, Transitional Cell trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Country / region: Hungary Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20172
20181
20194
20211
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Basilea Pharmaceutica1
Bayer1
EMD Serono Research & Development Institute, Inc.1
G1 Therapeutics, Inc.1
Hoffmann-La Roche1
Incyte Corporation1
Merck Sharp & Dohme LLC1
Pfizer1
Rainier Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell13
Urinary Bladder Neoplasms7
Carcinoma, Non-Small-Cell Lung2
Acrocephalosyndactylia1
Carcinoma, Hepatocellular1
Carcinoma, Renal Cell1
Neoplasm Metastasis1
Ovarian Neoplasms1
Small Cell Lung Carcinoma1
Urethral Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.